Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eloxx Pharmaceuticals Inc (ELOX)
  7. News

ELOX

Eloxx Pharmaceuticals Inc
4.00
-0.18 (-4.31%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Eloxx Pharmaceuticals Inc ELOX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.18 -4.31% 4.00 18:20:26
Open Price Low Price High Price Close Price Prev Close
4.17 3.99 4.17 4.00 4.18
more quote information »

Recent News

Date Time Source Heading
1/27/202316:04EDGARStatement of Changes in Beneficial Ownership (4)
1/27/202316:03EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202308:00GLOBEEloxx Pharmaceuticals Announces First Patients Enrolled in..
12/01/202208:45GLOBEEloxx Pharmaceuticals Announces Reverse Stock Split..
11/14/202216:19EDGARCurrent Report Filing (8-k)
11/10/202217:15GLOBEEloxx Pharmaceuticals Reports Third Quarter 2022 Financial..
11/10/202216:22EDGARQuarterly Report (10-q)
11/01/202216:30GLOBEEloxx Pharmaceuticals Announces Opening of Clinical Trial..
10/31/202216:32EDGARProxy Statement (definitive) (def 14a)
10/14/202216:32EDGARCurrent Report Filing (8-k)
9/15/202208:09EDGARCurrent Report Filing (8-k)
9/14/202216:05GLOBEEloxx Pharmaceuticals Reports Topline Results from Phase 2..
8/15/202216:21EDGARCurrent Report Filing (8-k)
8/15/202208:00GLOBEEloxx Pharmaceuticals Reports Second Quarter 2022 Financial..
7/15/202207:07EDGARCurrent Report Filing (8-k)
7/05/202208:29EDGARCurrent Report Filing (8-k)
7/05/202208:00GLOBEEloxx Pharmaceuticals Announces Changes to Board of..
6/17/202208:30EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202208:29EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202208:28EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202208:28EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202208:27EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202208:27EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202208:25EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202208:24EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202216:11EDGARCurrent Report Filing (8-k)
5/10/202218:31EDGARCurrent Report Filing (8-k)
5/10/202208:00GLOBEEloxx Pharmaceuticals Reports First Quarter 2022 Financial..
5/09/202206:30TRMNEloxx Pharmaceuticals (ELOX) Gets a Hold Rating from H.C...
5/06/202217:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/06/202216:22EDGARQuarterly Report (10-q)
4/29/202216:41EDGARProxy Statement (definitive) (def 14a)
4/29/202216:23EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/04/202208:45EDGARCurrent Report Filing (8-k)
3/31/202219:25TRMNEloxx Pharmaceuticals (ELOX) Receives a Buy from B.Riley..
3/31/202209:37SEEKEloxx Pharmaceuticals GAAP EPS of -$0.14 misses by $0.02
3/31/202207:00GLOBEEloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial..
3/31/202206:27TRMNH.C. Wainwright Keeps a Hold Rating on Eloxx Pharmaceuticals..
3/30/202217:26EDGARAnnual Report (10-k)
3/30/202217:20SEEKEloxx Pharma to target Alport syndrome with lead candidate
3/30/202216:15GLOBEEloxx Pharmaceuticals Announces New Development Program for..
3/29/202207:00GLOBEEloxx Pharmaceuticals Announces Therapeutic Development..
2/14/202206:27EDGARAmended Statement of Ownership (sc 13g/a)
2/03/202216:18EDGARAmended Statement of Beneficial Ownership (sc 13d/a)